product summary
company name :
Developmental Studies Hybridoma Bank
product type :
antibody
product name :
dystrophin fragment encoded by exons 4-16
catalog :
MANEX1216D(8D11)
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
MANEX1216D(8D11)
reactivity :
human
application :
western blot
more info or order :
citations: 1
Reference |
---|
Bartlett R, Stockinger S, Denis M, Bartlett W, Inverardi L, Le T, et al. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat Biotechnol. 2000;18:615-22 pubmed
|
product information
Internal ID :
8203
Name :
MANEX1216D(8D11)
Depositor Name :
Morris, G.E.
Depositor Institution :
Wolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry, UK
Date Deposited :
8/22/12
Allow Hybridoma Distribution :
Yes
Cells Available (legacy) :
Yes
Antigen :
dystrophin fragment encoded by exons 4-16
Antigen Species :
human
Host Species :
mouse
Isotype :
MIgG2a
Isotype for catalog (legacy) :
IgG1
Positive Tested Species Reactivity :
Human
Species Tested (legacy) :
human, (not mouse, not xenopus)
Initial Publication Pubmed ID :
10835598
Depositor Notes (Special Instructions) :
This antibody does not work for Immunofluorescence. This antibody does not work with mouse or Xenopus.
Search Keywords :
morris, dystrophin fragment encoded by exons 4-16, dmd, monoclonal, human, IgG2a, Western Blot
Gene :
DMD
Uniprot ID :
P11532
Antibody Registry ID :
AB_2618173
Clonality :
Monoclonal
Epitope Mapped :
Yes
Epitope Location or Sequence :
ex12,aaPLGPDL-DL by phage display
Recommended Applications :
Western Blot
Immunoblotting (legacy) :
yes
Additional Information :
RRID:AB_2618173
Additional Characterization :
http://www.glennmorris.org.uk/datasheets/MANEX1216D(8D11).doc
DSHB Growth Medium :
Iscove's
References (legacy) :
Nat. Biotechnol. 18, 615-622.
more info or order :
company information
Developmental Studies Hybridoma Bank
review
product type
related products
browse more products
questions and comments